Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00093704
Status:
TERMINATED
Last Update Posted:
2020-07-31
First Post:
2004-10-06
Brief Title:
Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma
Sponsor:
Jonsson Comprehensive Cancer Center
Organization:
Jonsson Comprehensive Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
| Lymphoproliferative Disorder |